8 Best Tumor Marker CA 15-3 Doctors in India

Dr. Shruti Kate is a medical oncology specialist at HCG Manavata Cancer Centre. She provides expert consultation on breast cancer markers including CA 15-3.

• Trained at Tata Memorial Hospital – India's premier cancer treatment and research center
• Presented lung cancer research at the 2018 World Conference in Toronto
• Member of ASCO and ESMO to ensure international medical standards
• Specializes in immunotherapy and metronomic therapy for aggressive cancers
• Recieved the National Travel Award for her contributions to oncology research

Dr. Sridhar P.S. is a specialist in radiation oncology at HCG Manavata Cancer Centre. He focuses on cancer detection and monitoring using tools like the Tumor marker CA 15-3.

• Earned a Doctor of Medicine in radiotherapy from Banaras Hindu University
• Holds a Diplomate of National Board certification in radiotherapy
• Member of the Indian Association of Hyperthermia Oncology
• Belongs to the Society for Neuro-Oncology for brain tumor expertise
• Active in the Association of Radiation Oncology of India

Dr. Chaitainya Borde has handled more than 30,000 PET scans at HCG Manavata Cancer Centre. He integrates CA 15-3 tumor marker testing with advanced nuclear imaging for breast cancer monitoring.

• Specializes in nuclear medicine – provides expert interpretation of complex diagnostic scans
• Experienced in PET-CT scans for precise cancer staging and monitoring
• Treated 1,000 thyroid cancer patients using targeted radioisotope therapies
• Published research papers on diagnostic accuracy in various medical journals

Dr. Sudarshan Pandit is a hematologist and clinical oncologist at HCG Manavata Cancer Centre. He specializes in hemato-oncology and bone marrow transplantation. He treats blood cancers such as leukemia, lymphoma, and myeloma, and manages non-cancerous conditions including aplastic anemia and thrombocytopenia.

• Performs bone marrow transplants for malignant and benign blood disorders.
• Treats Hodgkin’s and Non-Hodgkin’s lymphoma.
• Works at HCG Manavata, an NABH and NABL accredited cancer specialty hospital.
• Practices in a facility that treats over 75,000 patients annually.

Dr. Ahmer Arif Shaikh holds a fellowship in Head and Neck Surgical Oncology. He works at the NABH-accredited HCG Manavata Cancer Centre during tumor marker CA 15-3 evaluations.

• Treats oral and maxillofacial cancers using organ preservation techniques
• Performs lymphadenectomy to check if cancer has spread to local lymph nodes
• Former researcher with publications in several national and international medical journals
• Master of Dental Surgery from Rajasthan University of Health Sciences
• Focuses on early diagnosis for improved patient functional rehabilitation

10,000 major surgeries performed – Dr. Lalit Banswal is a leading surgical oncologist at HCG Manavata Cancer Centre.

• Performed over 10,000 major operations on complex cancer cases
• Fellowship trained in surgical oncology at Tata Medical Centre in Kolkata
• Served as head investigator for clinical research at Tata Medical Center
• Assistant Professor at the State Cancer Institute and Government Cancer Hospital
• Uses CA 15-3 marker screening to help monitor breast cancer status

Dr. Shaunak Valame specializes in molecular oncology at the HCG Manavata Cancer Centre. He uses tumor marker CA 15-3 to monitor breast cancer treatment and track patient progress.

• Trained in medical oncology at Indraprastha Apollo Hospital in New Delhi
• Member of the American Society of Clinical Oncology (ASCO)
• Presented stomach cancer research at the 2020 ASCO Symposium in San Francisco
• Focuses on targeted therapies for breast, gynecological, and solid tumors
• Performs supportive procedures like port insertions for chemotherapy delivery

With 50,000+ cancer surgeries performed, Dr. Nagarkar is the Chief of Surgical Oncology at HCG Manavata Cancer Centre. He uses the tumor marker CA 15-3 to monitor breast cancer treatment.

• Specializes in breast surgical oncology after training at the prestigious Tata Memorial Hospital
• Member of the Royal College of Surgeons of Edinburgh in the UK
• Professor for DNB Superspecialty Surgical Oncology – trains the next generation of cancer surgeons
• Contributed to 200+ clinical trials testing new protocols for various cancer types